PCIDB

KNApSAcK Metabolite C00004677

Metabolite

KNApSAcK Entry

id C00004677
Name Quercetagetin
CAS RN 90-18-6
Standard InChI InChI=1S/C15H10O8/c16-6-2-1-5(3-7(6)17)15-14(22)13(21)10-9(23-15)4-8(18)11(19)12(10)20/h1-4,16-20,22H
Standard InChI (Main Layer) InChI=1S/C15H10O8/c16-6-2-1-5(3-7(6)17)15-14(22)13(21)10-9(23-15)4-8(18)11(19)12(10)20/h1-4,16-20,22H

Cluster

Phytochemical cluster No. 15
KCF-S cluster No. 3

Link

ChEMBL

By standard InChI CHEMBL413552
By standard InChI Main Layer CHEMBL413552

KEGG

By LinkDB C10122

CTD

By CAS RN C079163

Human Protein / Gene in interaction

3 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P28907 ADP-ribosyl cyclase 1 Enzyme CHEMBL413552 CHEMBL1799589 (1)
0 / 1
P11309 Serine/threonine-protein kinase pim-1 Pim CHEMBL413552 CHEMBL926333 (2) CHEMBL1022925 (1)
CHEMBL957365 (1) CHEMBL960126 (1)
0 / 0
P04745 Alpha-amylase 1 Enzyme CHEMBL413552 CHEMBL964479 (2)
0 / 0

CTD interaction (1)

compound gene gene name gene description interaction interaction type form reference
pmid
C079163 5320 PLA2G2A
MOM1
PLA2
PLA2B
PLA2L
PLA2S
PLAS1
sPLA2
phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) quercetagetin affects the activity of PLA2G2A protein affects activity
protein 8190018

Related Disease

Diseases related to proteins in ChEMBL interactions

KEGG DISEASE (1)

KEGG disease name UniProt
H00005 Chronic lymphocytic leukemia (CLL) P28907 (marker)

Diseases related to CTD interactions

1 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D004487 C079163 Edema therapeutic
8190018